An in vivo platform for identifying inhibitors of protein aggregation
Open Access
- 14 December 2015
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 12 (2) , 94-101
Abstract
Applying an in vivo bacterial-based system for monitoring the influence of small molecules on the aggregation of model amyloid proteins expressed in the periplasm identified dopamine as a new inhibitor of hIAPP aggregation, a protein involved in type 2 diabetes mellitus. Protein aggregation underlies an array of human diseases, yet only one small-molecule therapeutic targeting this process has been successfully developed to date. Here, we introduce an in vivo system, based on a β-lactamase tripartite fusion construct, that is capable of identifying aggregation-prone sequences in the periplasm of Escherichia coli and inhibitors that prevent their aberrant self-assembly. We demonstrate the power of the system using a range of proteins, from small unstructured peptides (islet amyloid polypeptide and amyloid β) to larger, folded immunoglobulin domains. Configured in a 48-well format, the split β-lactamase sensor readily differentiates between aggregation-prone and soluble sequences. Performing the assay in the presence of 109 compounds enabled a rank ordering of inhibition and revealed a new inhibitor of islet amyloid polypeptide aggregation. This platform can be applied to both amyloidogenic and other aggregation-prone systems, independent of sequence or size, and can identify small molecules or other factors able to ameliorate or inhibit protein aggregation.Keywords
This publication has 56 references indexed in Scilit:
- Fibrillar α-Synuclein and Huntingtin Exon 1 Assemblies Are Toxic to the CellsBiophysical Journal, 2012
- Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibersProtein Science, 2012
- Genetic selection designed to stabilize proteins uncovers a chaperone called SpyNature Structural & Molecular Biology, 2011
- Inhibition of Glycosaminoglycan-Mediated Amyloid Formation by Islet Amyloid Polypeptide and proIAPP Processing IntermediatesJournal of Molecular Biology, 2011
- Conformational Conversion during Amyloid Formation at Atomic ResolutionMolecular Cell, 2011
- Efficient Microwave-Assisted Synthesis of Human Islet Amyloid Polypeptide Designed to Facilitate the Specific Incorporation of Labeled Amino AcidsOrganic Letters, 2010
- The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid FormationJournal of Molecular Biology, 2010
- Optimizing Protein Stability In VivoMolecular Cell, 2009
- Discovery of amyloid‐beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubilityProtein Science, 2008
- The Alzheimer’s Peptides Aβ40 and 42 Adopt Distinct Conformations in Water: A Combined MD / NMR StudyJournal of Molecular Biology, 2007